Resolution of Human Immunodeficiency Virus Type 1 Infection-Related Severe Pulmonary Hypertension in a Very Low-Birth-Weight Infant

    loading  Checking for direct PDF access through Ovid


Pulmonary arterial hypertension (PAH) affects approximately 0.5% of human immunodeficiency virus (HIV)-infected adults with poor prognosis. The effectiveness of highly active antiretroviral therapy for treatment of HIV-related PAH (HIV-PAH) remains controversial. Little is known about the incidence, clinical course, and therapy options for PAH in HIV-1-infected pediatric patients. Here, we report the case of a preterm infant with HIV-related life-threatening PAH, which resolved after initiation of highly active antiretroviral therapy.

    loading  Loading Related Articles